Key facts
- Mycophyto’s last known valuation is $9.0M (Dec 2022).
- It has raised $25.6M; the latest was Later Stage VC ($18.8M) in Jan 2026.
- Notable investors include Creative Destruction Lab, Bpifrance, Noshaq, Turenne Groupe, Région Sud Investissement — 23 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 23 names
- ·Watchlist + deal alerts for Mycophyto
- ·The full record, as it builds
Funding rounds
No funding rounds for Mycophyto are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Mycophyto
Operator of an agritech biotechnology company intended to restore soil biodiversity and support more environmentally friendly farming practices. The company develops natural soil and plant health systems based on mycorrhizal fungi, beneficial microorganisms that live in symbiosis with plant roots by improving plants' ability to absorb water and nutrients, enabling clients to improve crop yields, increase resilience to drought and stress, and reduce the need for chemical fertilizers and pesticides.
- Sector
- Materials and Resources
- HQ
- Grasse, France
- Founded
- 2016
- Employees
- 39
- Website
- mycophyto.fr/
- Ownership
- Privately Held (backing)
Mycophyto doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Mycophyto shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Mycophyto in its N-PORT filings yet. We sweep new filings monthly.